FDA Approves New Drug for Deadly Lung Cancer

  • 📰 MedicineNet
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

FDA Approves New Drug For Deadly Lung Cancer News

United States Latest News,United States Headlines

The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer.

The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly]," Dr. Jay Bradner, executive vice president of research and development and chief scientific officer at drug maker Amgen, said in a company news release. "Imdelltra offers these patients who are in urgent need of new innovative therapies hope, and we're proud to deliver this long-awaited effective treatment to them.

In a company trial, tarlatamab tripled patients' life expectancy, giving them a median survival of 14 months. But not everyone benefited: Forty percent of those who got the drug responded.] treatment landscape, there is now an effective and innovative treatment option available," Laurie Fenton Ambrose, co-founder, president and CEO of GO2 for Lungeffectiveness, it does have a serious side effect called a cytokine release syndrome, the FDA said.

had small cell lung cancer. After chemotherapy and immunotherapy, with her cancer still spreading rapidly, she was accepted into the Amgen study and began getting infusions of the drug.New York TimesLearn about lung cancer symptoms and treatments. Get more information on small cell lung cancer, non-small cell lung cancer, and the diagnosis of lung cancer stages.

Source: Healthcare Press (healthcarepress.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 575. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA Approves New Bladder Cancer DrugThe first-in-class agent is approved alongside bacillus Calmette-Guérin to treat certain non–muscle-invasive bladder cancers that do not respond to bacillus Calmette-Guérin alone.
Source: Medscape - 🏆 386. / 55 Read more »

Hot flashes treatment: FDA approves new drug for night sweatsLinda Carroll is a regular health contributor to NBC News. She is coauthor of 'The Concussion Crisis: Anatomy of a Silent Epidemic' and 'Out of the Clouds: The Unlikely Horseman and the Unwanted Colt Who Conquered the Sport of Kings.'
Source: NBCNews - 🏆 10. / 86 Read more »

FDA Approves New Antibiotic for Uncomplicated UTIsThe US Food and Drug Administration has approved pivmecillinam (Pivya) tablets to treat uncomplicated urinary tract infections in women.
Source: Medscape - 🏆 386. / 55 Read more »

FDA Approves New Antibiotic Against UTIsAs many patients already know, urinary tract infections (UTIs) can recur despite the use of antibiotics.
Source: MedicineNet - 🏆 575. / 51 Read more »

What to know about self-swabbing for HPV after FDA approves new kitsFor the first time, women in the United States have the ability to self-collect a sample to screen for human papillomavirus (HPV).
Source: ABC7 - 🏆 67. / 68 Read more »

FDA Approves Pivya, a New Treatment for UTIs in WomenFor the first time in two decades, the FDA has approved a new antibiotic to treat uncomplicated UTIs in women. Find out more about the new drug.
Source: Health - 🏆 396. / 53 Read more »